By Neil Charness, Ph.D., Director, Institute for Successful Longevity
Blog
Transportation innovation has been evolving significantly for at least 10 years. But this evolution of electric, automated, and on-demand services is leaving persons with disabilities (PWDs) and many older adults on the curb.
Damaris Aschwanden, Ph.D., is a post-doctoral researcher in FSU's College of Medicine and works in the LPC Lifespan Lab with Professor Antonio Terracciano, Professor Angelina R. Sutin and Assistant Professor Martina Luchetti. All are Faculty Affiliates of the Institute for Successful Longevity. You can watch Dr.
I recently wrote about the need to plan ways to transfer your digital assets to heirs, particularly in light of the increased deployment of two-factor authentication
The Centers for Disease Control and Prevention and the National Center for Health Statistics recently released estimates for Life Expectancy at Birth in the United States for 2020: https://www.cdc.gov/nchs/data/vsrr/VSRR015-508.pdf. As might be expected during the COVID-19 pandemic, the figures are grim. We have lost about 1.5 years of life expectancy, with subgroups such as Latinos and African Americans experiencing even worse declines: 3 years and 2.9 yea
You may have seen news stories about the controversy over the newest Alzheimer’s Disease drug, Aduhelm/aducanumab, recently approved by the Food and Drug Administration, https://www.fda.gov/news-events/press-announcements/fda-grants-accelerated-approval-alzheimers-drug and later defended in a press release by the FDA after intense criticism:
Aaron Wilber, Ph.D., is Assistant Professor in the Department of Psychology and is affiliated with the Program in Neuroscience. He is a Faculty Affiliate of the Institute for Successful Longevity.
Amy L. Ai, Ph.D., is a professor in the College of Social Work and a Faculty Affiliate of the Institute for Successful Longevity. She is also Fellow of the Gerontological Society of America, American Psychologist Association, and Association of Psychological Science. In 2020, the American Psychological Association’s Division 56 (Trauma Psychology) honored her with its Outstanding Science Award. Professor Ai will give a presentation on her research December 6 as part of the ISL Brown Bag Series.
More and more people 65 and older are fortunate to be receiving their first doses of Covid-19 vaccine with more doses hopefully released soon for the rest of the population. If you are one of the lucky pioneers with the first approved vaccines, congratulations on getting a dose, or doses, as this is the first step down a long road toward rolling back the pandemic.
Long-term effects of COVID-19 infection may shape cognitive health in an aging society
By Neil Charness, Ph.D., Director, Institute for Successful Longevity
Through designs and decisions, automakers are leaving behind persons with disabilities
Transportation innovation has been evolving significantly for at least 10 years. But this evolution of electric, automated, and on-demand services is leaving persons with disabilities (PWDs) and many older adults on the curb.
Being disciplined and organized makes you 23% less likely to develop dementia
Damaris Aschwanden, Ph.D., is a post-doctoral researcher in FSU's College of Medicine and works in the LPC Lifespan Lab with Professor Antonio Terracciano, Professor Angelina R. Sutin and Assistant Professor Martina Luchetti. All are Faculty Affiliates of the Institute for Successful Longevity. You can watch Dr.
Two-Factor Authentication, revisited: How to transfer your digital information
I recently wrote about the need to plan ways to transfer your digital assets to heirs, particularly in light of the increased deployment of two-factor authentication
An end to the aging of the population? What the new numbers on life expectancy could mean
The Centers for Disease Control and Prevention and the National Center for Health Statistics recently released estimates for Life Expectancy at Birth in the United States for 2020: https://www.cdc.gov/nchs/data/vsrr/VSRR015-508.pdf. As might be expected during the COVID-19 pandemic, the figures are grim. We have lost about 1.5 years of life expectancy, with subgroups such as Latinos and African Americans experiencing even worse declines: 3 years and 2.9 yea
The controversy over Aduhelm – newest approved drug for Alzheimer’s disease — and why scientists are alarmed
You may have seen news stories about the controversy over the newest Alzheimer’s Disease drug, Aduhelm/aducanumab, recently approved by the Food and Drug Administration, https://www.fda.gov/news-events/press-announcements/fda-grants-accelerated-approval-alzheimers-drug and later defended in a press release by the FDA after intense criticism:
Recent findings in mice suggest that Alzheimer’s disease may change brain function during sleep leading to memory loss and impairments in navigating our surroundings
Aaron Wilber, Ph.D., is Assistant Professor in the Department of Psychology and is affiliated with the Program in Neuroscience. He is a Faculty Affiliate of the Institute for Successful Longevity.
Gender difference and medical factors in postoperative outcomes among older patients undergoing open-heart surgery
Amy L. Ai, Ph.D., is a professor in the College of Social Work and a Faculty Affiliate of the Institute for Successful Longevity. She is also Fellow of the Gerontological Society of America, American Psychologist Association, and Association of Psychological Science. In 2020, the American Psychological Association’s Division 56 (Trauma Psychology) honored her with its Outstanding Science Award. Professor Ai will give a presentation on her research December 6 as part of the ISL Brown Bag Series.
You’ve gotten the vaccine ... can life now return to normal?
More and more people 65 and older are fortunate to be receiving their first doses of Covid-19 vaccine with more doses hopefully released soon for the rest of the population. If you are one of the lucky pioneers with the first approved vaccines, congratulations on getting a dose, or doses, as this is the first step down a long road toward rolling back the pandemic.